These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 21780307)

  • 1. A brief history of 'new psychoactive substances'.
    King LA; Kicman AT
    Drug Test Anal; 2011; 3(7-8):401-3. PubMed ID: 21780307
    [No Abstract]   [Full Text] [Related]  

  • 2. Designer drugs: a medicinal chemistry perspective (II).
    Carroll FI; Lewin AH; Mascarella SW; Seltzman HH; Reddy PA
    Ann N Y Acad Sci; 2021 Apr; 1489(1):48-77. PubMed ID: 32396701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Where is the pleasure?
    Ritter A
    Addiction; 2014 Oct; 109(10):1587-8. PubMed ID: 25163703
    [No Abstract]   [Full Text] [Related]  

  • 4. New Psychoactive Substances (NPS) - the Hydra monster of recreational drugs.
    Helander A; Bäckberg M
    Clin Toxicol (Phila); 2017 Jan; 55(1):1-3. PubMed ID: 27549399
    [No Abstract]   [Full Text] [Related]  

  • 5. [Recent history of psychoactive drugs].
    González M
    Rev Enferm; 2002 Oct; 25(10):53-60. PubMed ID: 13677761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The development of psychotropic drug chemistry over the past 20 years (author's transl)].
    Protiva M
    Cesk Psychiatr; 1978 Dec; 74(6):337-49. PubMed ID: 389466
    [No Abstract]   [Full Text] [Related]  

  • 7. Changes in the prevalence of new psychoactive substances before and after the introduction of the generic scheduling of synthetic cannabinoids in Japan.
    Kikura-Hanajiri R; Kawamura NU; Goda Y
    Drug Test Anal; 2014; 6(7-8):832-9. PubMed ID: 24573957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FAPA mass spectrometry of designer drugs.
    Smoluch M; Gierczyk B; Reszke E; Babij M; Gotszalk T; Schroeder G; Silberring J
    Talanta; 2016; 146():29-33. PubMed ID: 26695230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of a putative new psychoactive substance, 2-(2-(4-chlorophenyl)acetamido)-3-methylbutanamide, in Spain.
    Fabregat-Safont D; Fornís I; Ventura M; Gil C; Calzada N; Sancho JV; Hernández F; Ibáñez M
    Drug Test Anal; 2017 Jul; 9(7):1073-1080. PubMed ID: 28266810
    [No Abstract]   [Full Text] [Related]  

  • 10. DART-MS in-source collision induced dissociation and high mass accuracy for new psychoactive substance determinations.
    Musah RA; Cody RB; Domin MA; Lesiak AD; Dane AJ; Shepard JR
    Forensic Sci Int; 2014 Nov; 244():42-9. PubMed ID: 25194642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of collision-induced dissociation of electrospray-generated protonated cathinones.
    Fornal E
    Drug Test Anal; 2014; 6(7-8):705-15. PubMed ID: 24259394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Recreational drugs: the complication's pleasure?].
    Joye F; Donzé N; Frochaux V; Niquille M; Selz Amaudruz F
    Rev Med Suisse; 2013 Aug; 9(394):1454-60. PubMed ID: 24024389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic cathinones: chemistry, pharmacology and toxicology of a new class of designer drugs of abuse marketed as "bath salts" or "plant food".
    Coppola M; Mondola R
    Toxicol Lett; 2012 Jun; 211(2):144-9. PubMed ID: 22459606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinguishing two isomeric mephedrone substitutes with selective reagent ionisation mass spectrometry (SRI-MS).
    Lanza M; Acton WJ; Jürschik S; Sulzer P; Breiev K; Jordan A; Hartungen E; Hanel G; Märk L; Mayhew CA; Märk TD
    J Mass Spectrom; 2013 Sep; 48(9):1015-8. PubMed ID: 24078242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychoactive 'bath salts': compounds, mechanisms, and toxicities.
    Lehner KR; Baumann MH
    Neuropsychopharmacology; 2013 Jan; 38(1):243-4. PubMed ID: 23147485
    [No Abstract]   [Full Text] [Related]  

  • 16. Designer drugs: a medicinal chemistry perspective.
    Carroll FI; Lewin AH; Mascarella SW; Seltzman HH; Reddy PA
    Ann N Y Acad Sci; 2012 Feb; 1248():18-38. PubMed ID: 22092008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implications of psychoactive 'bath salts' use during pregnancy.
    Gray BA; Holland C
    Nurs Womens Health; 2014; 18(3):220-30. PubMed ID: 24939199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of synthetic cathinones and associated psychoactive substances by ion mobility spectrometry.
    Joshi M; Cetroni B; Camacho A; Krueger C; Midey AJ
    Forensic Sci Int; 2014 Nov; 244():196-206. PubMed ID: 25259942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzyme Inhibition and more--a tribute to John Smith.
    Supuran CT
    J Enzyme Inhib Med Chem; 2011 Jun; 26(3):301-2. PubMed ID: 21524148
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug addiction. Part I. Psychoactive substances in the past and presence.
    Vetulani J
    Pol J Pharmacol; 2001; 53(3):201-14. PubMed ID: 11785921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.